Christine A. Rabinak
Wayne State University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christine A. Rabinak as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:05 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04080427 · Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 StudyWayne State University · completed · Posttraumatic Stress Disorder
- Ph4NCT03008005 · Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 StudyWayne State University · completed · PostTraumatic Stress Disorder · principal investigator
- N/ANCT02069366 · Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress DisorderWayne State University · completed · Post-Traumatic Stress Disorder · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:05 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Cannabidiol-enhanced cognitive behavioral therapy for generalized anxiety disorderR61MH137105 · NIMH · WAYNE STATE UNIVERSITY · fiscal years 2025 to 2026 · $1,701,056 awarded in 2026Same name and institution; not confirmed by an ID
- Effects of THC on Retention of Memory for Fear Extinction Learning in PTSDR33MH111935 · NIMH · WAYNE STATE UNIVERSITY · fiscal years 2020 to 2022 · $720,605 awarded in 2022Same name and institution; not confirmed by an ID
- Effects of THC on Retention of Memory for Fear Extinction Learning in PTSDR61MH111935 · NIMH · WAYNE STATE UNIVERSITY · fiscal years 2017 to 2018 · $705,443 awarded in 2018Grant number is on one of their registry trials
- Cannabinoid Control of Fear Extinction Neural Circuits in Post Traumatic Stress dK01MH101123 · NIMH · WAYNE STATE UNIVERSITY · fiscal years 2014 to 2017 · $139,075 awarded in 2017Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 10:05 UTC. The ranking covers the 200 most relevant of 11 PubMed records, and a shared surname and initials can bring in a namesake. All 11 on PubMed
- Cannabinoid facilitation of fear extinction memory recall in humans.Neuropharmacology · 2013136 citationsRCR 5.0
- Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans.Neurobiol Learn Mem · 2014116 citationsRCR 4.4
- Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study.Psychopharmacology (Berl) · 202043 citationsRCR 3.0
- Influence of Δ9-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans.Neuropsychopharmacology · 201933 citationsRCR 1.9
- Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect.Neuropsychopharmacology · 201628 citationsRCR 1.2
- Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect.J Neural Transm (Vienna) · 201223 citationsRCR 0.8
- Effects of acute Δ9-tetrahydrocannabinol on next-day extinction recall is mediated by post-extinction resting-state brain dynamics.Neuropharmacology · 201820 citationsRCR 1.0
- Cannabinoid modulation of corticolimbic activation during extinction learning and fear renewal in adults with posttraumatic stress disorder.Neurobiol Learn Mem · 202319 citationsRCR 3.1
- Dose-dependent effect of acute THC on extinction memory recall and fear renewal: a randomized, double-blind, placebo-controlled study.Psychopharmacology (Berl) · 202611 citationsRCR 5.5
- Cannabinoid modulation of brain activation during volitional regulation of negative affect in trauma-exposed adults.Neuropharmacology · 20228 citationsRCR 0.9